Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > Bloom Burton update $0.80 tp
View:
Post by lscfa on Feb 15, 2024 8:53am

Bloom Burton update $0.80 tp

.
Comment by lscfa on Feb 15, 2024 8:56am
2024 revenue $25.2M....2024 ebitda $4.7M
Comment by wizzdumb on Feb 15, 2024 10:42am
Can someone post link to report please. 
Comment by Mbxwatcher on Feb 15, 2024 1:23pm
https://microbix.com/wp-content/Microbix%20QR_1%202024%20v3B%20FINAL%20PRINT.pdf
Comment by Mbxwatcher on Feb 15, 2024 1:46pm
sorry realized afterwards thats not what you were looking for. Love to see it as well if anyone has it.
Comment by yielddude on Feb 15, 2024 3:23pm
this on yahoo, matches .80, but doesn't say who ... ? Down towards bottom ... https://finance.yahoo.com/quote/MBX.TO?.tsrc=fin-srch https://finance.yahoo.com/quote/MBX.TO/analysis
Comment by RICHOFFMBX on Feb 15, 2024 9:42pm
Here it is: https://www.bloomburton.com/research/MBX20240215.pdf
Comment by RICHOFFMBX on Feb 15, 2024 9:58pm
Note in their analysis that Kinlytic is not factored into TP.
Comment by wizzdumb on Feb 16, 2024 9:06am
Yes, I'd say it's a reasonable but conservative analysis of their core business but key is it does not factor in Kinlytic. So basically today you're getting the core business at half of conservative valuation and an option on Kinlytic, a massive opportunity that one the worlds largest healthcare private equity firms is spending $50M on pre revenue and that has little to no clinical ...more  
Comment by mercedesman on Feb 16, 2024 9:11am
That's what is most amazing to me.  the Target Price is basically a double from here with nothing factored in for future Kinlytic royalties which are expected to be $15m to $25m USD annually a few years after launch ! Imagine what the discounted value of that very high margin stream of cash is worth in Market Cap ?  10X at least but to be conservative discount that by 1/2 in ...more  
Comment by wizzdumb on Feb 16, 2024 9:25am
Yeah and for fun add in Europe which is a no brainer for CC indication only which will come with the same milestone payments and royalties as the US and likely launch either in parallel or soon after due to regulator pull. Then if you really want to blow your mind add in multiple other much larger opportunities for other Kinlytic indications globally. Warning - not for the faint of heart lol.  ...more  
Comment by lscfa on Feb 16, 2024 11:07am
Using Sequel forecasts....       Sequel sales Royalties 10% Milestone payments PV @ 20% PV @ 15% PV @ 10% 0         & ...more  
Comment by wizzdumb on Feb 16, 2024 11:47am
Where are you getting $30M sales milestone payment schedule and royalty percentage? As far as I know those are not released. 
Comment by lscfa on Feb 16, 2024 12:00pm
Milestone payment timing is my asumption.  KRC assumed 10% royalty and milestones starting in 2029 and he is paid by MBX to create report so probably has input from co.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities